1.10
price down icon2.65%   -0.03
after-market After Hours: 1.05 -0.05 -4.55%
loading

Cns Pharmaceuticals Inc Stock (CNSP) Forecast

The Cns Pharmaceuticals Inc (CNSP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.86, representing a +978.16% increase from the current price of $1.10. The highest analyst price target is $16.94, and the lowest is $6.784.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNSP Price Target
Average 11.65 (+959.13% Upside)
loading

Is Cns Pharmaceuticals Inc (CNSP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 28.99 Buy
STOCH(9,6) 4.4306 Buy
STOCHRSI(14) 0.4787 Buy
MACD(12,26) -0.6563 Sell
ADX(14) 17.20 Neutral
William %R -97.49 Buy
CCI(14) -64.05 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
1.517
Sell
1.5848
Sell
MA20
2.319
Sell
2.1074
Sell
MA50
3.4362
Sell
3.3697
Sell
MA100
4.539
Sell
24.86
Sell
MA200
14.96
Sell
266.95
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, CNSP could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CNSP, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 28.99 indicates that CNSP is oversold. This indicates that CNSP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 4.4306 indicates that CNSP is oversold. This indicates that CNSP price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.4787 indicates that CNSP is oversold. This suggests that CNSP price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 17.2 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -64.05 indicates that CNSP is still oversold but not to an extreme extent.

Long-term CNSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cns Pharmaceuticals Inc financial reports and earnings history, Cns Pharmaceuticals Inc (CNSP) stock could reach $38.97 by 2030, $70.10 by 2040 and $319.69 by 2050. See the projected annual prices until 2050 of the Cns Pharmaceuticals Inc stock below:

  • Cns Pharmaceuticals Inc (CNSP) is expected to reach an average price of $74.03 in 2035, with a high prediction of $75.20 and a low estimate of $74.62. This indicates an $6,630% rise from the last recorded price of $1.10.
  • Cns Pharmaceuticals Inc (CNSP) stock is projected to chart a bullish course in 2040, with an average price target of $68.15, representing an $6,095% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $70.10.
  • Our analysts predict Cns Pharmaceuticals Inc (CNSP) to jump 3,071% by 2045, soaring from $36.04 to an average price of $34.88, potentially reaching $39.12. While $36.04 is the low estimate, the potential upside is significant.
  • Cns Pharmaceuticals Inc (CNSP) stock is expected to climb by 2050, reaching an average of $319.80, a $28,973% jump from its current level. However, a wide range of estimates exists, with high and low targets of $319.69 and $322.20, respectively, highlighting the market's uncertainty.

Cns Pharmaceuticals Inc Stock (CNSP) Year by Year Forecast

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2025

Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $25.20 in 2025, with a high prediction of $49.96 and a low estimate of $0.438. This indicates an +2,191% rise from the last recorded price of $1.10.
Month Average Low High Change from today's price
May, 2025 $11.19 $6.784 $16.94 +917.00%
June, 2025 $3.7929 $0.4929 $11.91 +244.81%
July, 2025 $6.5502 $3.5502 $10.94 +495.48%
August, 2025 $6.0561 $1.8032 $9.4532 +450.56%
September, 2025 $0.138 $0.438 $7.8076 -87.45%
October, 2025 $6.8306 $1.0865 $6.9649 +520.97%
November, 2025 $14.60 $9.7292 $9.0107 +1,228%
December, 2025 $16.39 $14.38 $15.43 +1,390%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2026

The predicted value for Cns Pharmaceuticals Inc (CNSP) in 2026 is set at an average of $19.55. Estimates vary from a peak of $22.86 to a trough of $16.25, indicating an +1,678% surge from the present price of $1.10.
Month Average Low High Change from today's price
January, 2026 $23.21 $21.54 $22.86 +2,010%
February, 2026 $22.51 $23.23 $22.22 +1,946%
March, 2026 $20.60 $21.75 $21.15 +1,773%
April, 2026 $21.45 $20.62 $20.43 +1,850%
May, 2026 $19.42 $20.50 $20.76 +1,665%
June, 2026 $19.73 $20.38 $19.97 +1,694%
July, 2026 $20.28 $19.98 $19.81 +1,744%
August, 2026 $18.15 $19.23 $19.27 +1,550%
September, 2026 $18.86 $17.81 $17.52 +1,614%
October, 2026 $18.04 $18.04 $17.93 +1,540%
November, 2026 $16.93 $17.20 $17.76 +1,439%
December, 2026 $18.55 $16.25 $18.47 +1,586%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Cns Pharmaceuticals Inc (CNSP) is $12.20, with a high forecast of $18.02 and a low forecast of $6.3775. This indicates an +1,009% increase from the last price of $1.10.
Month Average Low High Change from today's price
January, 2027 $17.43 $17.98 $18.02 +1,485%
February, 2027 $17.12 $17.17 $17.28 +1,456%
March, 2027 $16.22 $16.51 $16.54 +1,375%
April, 2027 $15.93 $16.08 $15.93 +1,348%
May, 2027 $14.17 $14.38 $15.63 +1,188%
June, 2027 $12.96 $13.18 $13.71 +1,078%
July, 2027 $11.64 $11.88 $12.67 +957.88%
August, 2027 $10.65 $10.67 $11.14 +868.25%
September, 2027 $9.5034 $9.5634 $10.29 +763.95%
October, 2027 $8.8375 $8.8475 $9.2519 +703.41%
November, 2027 $8.3816 $8.5016 $8.556 +661.97%
December, 2027 $6.1943 $6.3775 $8.0202 +463.12%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2028

In 2028, Cns Pharmaceuticals Inc (CNSP) is projected to reach an average price of $27.77, with a high projection of $55.28 and a low estimate of $0.2653. This indicates an +2,425% rise from the last price of $1.10.
Month Average Low High Change from today's price
January, 2028 $4.8784 $5.2984 $5.8848 +343.49%
February, 2028 $4.5225 $4.584 $4.627 +311.14%
March, 2028 $4.2152 $4.3466 $4.3495 +283.20%
April, 2028 $3.7112 $3.752 $4.0747 +237.39%
May, 2028 $2.302 $2.4119 $3.4206 +109.27%
June, 2028 $1.4674 $1.476 $2.0024 +33.40%
July, 2028 $0.5087 $0.5201 $1.195 -53.75%
August, 2028 $39.48 $0.2653 $55.28 +3,489%
September, 2028 $52.17 $45.58 $46.47 +4,642%
October, 2028 $49.56 $52.86 $50.56 +4,405%
November, 2028 $40.44 $43.74 $49.05 +3,576%
December, 2028 $34.23 $37.03 $36.04 +3,012%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2029

The 2029 price forecast for Cns Pharmaceuticals Inc Stock (CNSP) is $23.76 on average, with a high prediction of $44.01 and a low estimate of $3.5003. This represents an +2,060% increase from the previous price of $1.10.
Month Average Low High Change from today's price
January, 2029 $45.21 $32.30 $44.01 +4,010%
February, 2029 $3.2974 $42.71 $39.61 +199.76%
March, 2029 $24.99 $3.5003 $36.80 +2,172%
April, 2029 $21.78 $16.43 $20.28 +1,880%
May, 2029 $30.96 $22.48 $27.06 +2,715%
June, 2029 $33.45 $34.95 $32.96 +2,941%
July, 2029 $24.84 $27.54 $25.94 +2,158%
August, 2029 $31.03 $29.14 $28.93 +2,721%
September, 2029 $37.41 $33.92 $32.50 +3,301%
October, 2029 $33.40 $32.31 $30.41 +2,936%
November, 2029 $32.89 $35.79 $33.39 +2,890%
December, 2029 $38.08 $33.58 $33.88 +3,361%

Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2030

Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $47.65 in 2030, with a high forecast of $56.53 and a low forecast of $38.77. This signifies an +4,232% surge from the last price of $1.10.
Month Average Low High Change from today's price
January, 2030 $43.51 $38.77 $38.97 +3,856%
February, 2030 $50.28 $45.96 $44.69 +4,471%
March, 2030 $51.84 $49.80 $49.24 +4,612%
April, 2030 $57.21 $51.57 $56.53 +5,101%
May, 2030 $54.91 $55.84 $56.03 +4,892%
June, 2030 $52.00 $53.39 $53.04 +4,627%
July, 2030 $51.59 $51.49 $50.57 +4,590%
August, 2030 $48.55 $49.63 $50.65 +4,314%
September, 2030 $47.86 $48.52 $48.60 +4,251%
October, 2030 $47.16 $47.61 $47.33 +4,187%
November, 2030 $44.01 $45.10 $45.89 +3,901%
December, 2030 $42.58 $42.67 $43.13 +3,771%
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):